Scientists test 'Kick and Kill' combo in quest for HIV remission
NCT ID NCT04357821
Summary
This early-stage study is testing a multi-part treatment strategy to see if people with HIV can safely stop their daily antiviral pills and keep the virus under control. Eleven participants on stable medication will receive a series of vaccine shots, two lab-made antibodies, and an immune stimulant, then carefully stop their regular pills to see if the new treatment can suppress the virus. The goal is to achieve a 'remission' where the virus stays at very low levels without daily medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zuckerberg San Francisco General Hospital, University of California San Francisco
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.